Ahvie Herskowitz MD
Dr. Herskowitz’s extensive training includes a medical degree from The Albert Einstein College of Medicine, residencies in Anatomic Pathology and Internal Medicine, and Fellowship training in Cardiology at The Johns Hopkins Medical Center. During his 12 years at Johns Hopkins, he became Associate Professor of Medicine and Immunology and Molecular Microbiology and led a research team in the study of molecular and immunological mechanisms of inflammation, autoimmunity, ischemia, heart transplantation rejection and congestive heart failure.
Over the past 15 years, he helped establish and lead innovative health care non-profit research and development organizations that have domestic and worldwide social impact. He was head of a 75-person research team at the Ischemia Research and Education Foundation, working with over 100 leading heart surgery hospitals around the world, reducing adverse outcomes during and after heart surgery. Since 1999, he has been Clinical Professor of Medicine at University of California at San Francisco, and Co-founder and Chief Medical Officer of the Institute for OneWorld Health, the first non-profit pharmaceutical company in the United States. He is President of the American College for Advancement in Medicine (ACAM), one of the most respected Integrative Medicine societies in the US; Chairman of the Board of Directors for iRND3, (www.irnd3.org) an organization that discovers new medicines for rare and neglected diseases, and serves on the Board for PVRI, Pulmonary Vascular Research Institute.
In 2010, he formed Anatara Medicine, based in San Francisco, to provide a world-class integrative medicine team approach towards prevention and treatment of vascular, immunologic, and difficult chronic diseases. He is also Founder of the San Francisco Stem Cell Treatment Center. With over four decades of experience in Medicine, Cardiology, Immunology, Regenerative Medicine, and Pathology, Dr. Herskowitz is one of most senior academic, anti-aging doctors in the U.S.